S&P 500   5,117.73 (-1.56%)
DOW   37,937.74 (-1.36%)
QQQ   438.43 (-1.56%)
AAPL   175.80 (+0.43%)
MSFT   422.04 (-1.38%)
META   512.43 (-2.05%)
GOOGL   157.62 (-1.12%)
AMZN   185.80 (-1.72%)
TSLA   171.64 (-1.70%)
NVDA   885.41 (-2.29%)
AMD   163.30 (-4.22%)
NIO   4.14 (-7.17%)
BABA   71.88 (-3.97%)
T   16.36 (-0.37%)
F   12.59 (-3.45%)
MU   122.68 (-3.79%)
GE   154.60 (-1.78%)
CGC   7.77 (-4.66%)
DIS   114.38 (-2.36%)
AMC   2.66 (-5.00%)
PFE   26.01 (-1.25%)
PYPL   64.42 (-2.10%)
XOM   121.04 (-0.62%)
S&P 500   5,117.73 (-1.56%)
DOW   37,937.74 (-1.36%)
QQQ   438.43 (-1.56%)
AAPL   175.80 (+0.43%)
MSFT   422.04 (-1.38%)
META   512.43 (-2.05%)
GOOGL   157.62 (-1.12%)
AMZN   185.80 (-1.72%)
TSLA   171.64 (-1.70%)
NVDA   885.41 (-2.29%)
AMD   163.30 (-4.22%)
NIO   4.14 (-7.17%)
BABA   71.88 (-3.97%)
T   16.36 (-0.37%)
F   12.59 (-3.45%)
MU   122.68 (-3.79%)
GE   154.60 (-1.78%)
CGC   7.77 (-4.66%)
DIS   114.38 (-2.36%)
AMC   2.66 (-5.00%)
PFE   26.01 (-1.25%)
PYPL   64.42 (-2.10%)
XOM   121.04 (-0.62%)
S&P 500   5,117.73 (-1.56%)
DOW   37,937.74 (-1.36%)
QQQ   438.43 (-1.56%)
AAPL   175.80 (+0.43%)
MSFT   422.04 (-1.38%)
META   512.43 (-2.05%)
GOOGL   157.62 (-1.12%)
AMZN   185.80 (-1.72%)
TSLA   171.64 (-1.70%)
NVDA   885.41 (-2.29%)
AMD   163.30 (-4.22%)
NIO   4.14 (-7.17%)
BABA   71.88 (-3.97%)
T   16.36 (-0.37%)
F   12.59 (-3.45%)
MU   122.68 (-3.79%)
GE   154.60 (-1.78%)
CGC   7.77 (-4.66%)
DIS   114.38 (-2.36%)
AMC   2.66 (-5.00%)
PFE   26.01 (-1.25%)
PYPL   64.42 (-2.10%)
XOM   121.04 (-0.62%)
S&P 500   5,117.73 (-1.56%)
DOW   37,937.74 (-1.36%)
QQQ   438.43 (-1.56%)
AAPL   175.80 (+0.43%)
MSFT   422.04 (-1.38%)
META   512.43 (-2.05%)
GOOGL   157.62 (-1.12%)
AMZN   185.80 (-1.72%)
TSLA   171.64 (-1.70%)
NVDA   885.41 (-2.29%)
AMD   163.30 (-4.22%)
NIO   4.14 (-7.17%)
BABA   71.88 (-3.97%)
T   16.36 (-0.37%)
F   12.59 (-3.45%)
MU   122.68 (-3.79%)
GE   154.60 (-1.78%)
CGC   7.77 (-4.66%)
DIS   114.38 (-2.36%)
AMC   2.66 (-5.00%)
PFE   26.01 (-1.25%)
PYPL   64.42 (-2.10%)
XOM   121.04 (-0.62%)
NASDAQ:GOCO

GoHealth (GOCO) Stock Price, News & Analysis

$10.11
-0.07 (-0.69%)
(As of 01:22 PM ET)
Today's Range
$9.89
$10.30
50-Day Range
$9.60
$14.07
52-Week Range
$7.05
$22.85
Volume
7,185 shs
Average Volume
15,073 shs
Market Capitalization
$227.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00

GoHealth MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
31.4% Upside
$13.00 Price Target
Short Interest
Bearish
2.95% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.22mentions of GoHealth in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($5.22) to ($4.33) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.30 out of 5 stars

Finance Sector

2290th out of 2,625 stocks

Insurance Agents, Brokers, & Service Industry

43rd out of 54 stocks

GOCO stock logo

About GoHealth Stock (NASDAQ:GOCO)

GoHealth, Inc. operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. It provides Medicare plans, including Medicare Advantage, Medicare Supplement and Prescription Drug, and Medicare Special Needs Plans. The company also offers partner marketing services. It sells its products through carriers and online platform, as well as independent and external agencies. The company was founded in 2001 and is headquartered in Chicago, Illinois.

GOCO Stock Price History

GOCO Stock News Headlines

These AI trades triggered this morning (545% return)
If you think a market crash is possible in 2024, I don't know why you're not using this yet.
GoHealth to Present at the LD Micro Invitational XIV
These AI trades triggered this morning (545% return)
If you think a market crash is possible in 2024, I don't know why you're not using this yet.
Earnings Outlook For GoHealth
GoHealth A earnings: here's what Wall Street expects
Is GoHealth (GOCO) a Great Value Stock Right Now?
GoHealth Inc.
GoHealth to Participate in November Conferences
GoHealth: Q3 Earnings Insights
See More Headlines
Receive GOCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GoHealth and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/14/2024
Today
4/12/2024
Next Earnings (Estimated)
5/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Insurance agents, brokers, & service
Sub-Industry
N/A
Current Symbol
NASDAQ:GOCO
Fax
N/A
Employees
2,530
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.00
High Stock Price Target
$13.00
Low Stock Price Target
$13.00
Potential Upside/Downside
+27.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-63,260,000.00
Pretax Margin
-20.57%

Debt

Sales & Book Value

Annual Sales
$734.67 million
Cash Flow
$3.17 per share
Book Value
$18.06 per share

Miscellaneous

Free Float
10,791,000
Market Cap
$228.85 million
Optionable
Not Optionable
Beta
1.79
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

GOCO Stock Analysis - Frequently Asked Questions

Should I buy or sell GoHealth stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for GoHealth in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" GOCO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GOCO, but not buy additional shares or sell existing shares.
View GOCO analyst ratings
or view top-rated stocks.

What is GoHealth's stock price target for 2024?

1 brokerages have issued 12 month target prices for GoHealth's stock. Their GOCO share price targets range from $13.00 to $13.00. On average, they expect the company's share price to reach $13.00 in the next twelve months. This suggests a possible upside of 31.4% from the stock's current price.
View analysts price targets for GOCO
or view top-rated stocks among Wall Street analysts.

How have GOCO shares performed in 2024?

GoHealth's stock was trading at $13.34 at the start of the year. Since then, GOCO stock has decreased by 25.9% and is now trading at $9.89.
View the best growth stocks for 2024 here
.

Are investors shorting GoHealth?

GoHealth saw a increase in short interest in March. As of March 31st, there was short interest totaling 223,400 shares, an increase of 8.9% from the March 15th total of 205,100 shares. Based on an average trading volume of 15,000 shares, the days-to-cover ratio is currently 14.9 days. Currently, 3.0% of the company's stock are short sold.
View GoHealth's Short Interest
.

When is GoHealth's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our GOCO earnings forecast
.

How were GoHealth's earnings last quarter?

GoHealth, Inc. (NASDAQ:GOCO) issued its earnings results on Thursday, March, 14th. The company reported $0.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.73 by $2.13. The business earned $276.70 million during the quarter, compared to the consensus estimate of $362.38 million. GoHealth had a negative net margin of 8.61% and a negative trailing twelve-month return on equity of 9.29%.

What is Matthew Crummack's approval rating as GoHealth's CEO?

25 employees have rated GoHealth Chief Executive Officer Matthew Crummack on Glassdoor.com. Matthew Crummack has an approval rating of 90% among the company's employees.

What other stocks do shareholders of GoHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GoHealth investors own include Tesla (TSLA), Alibaba Group (BABA), CVS Health (CVS), Moderna (MRNA), RTX (RTX), Walmart (WMT), Cisco Systems (CSCO), Intel (INTC) and Johnson & Johnson (JNJ).

When did GoHealth IPO?

GoHealth (GOCO) raised $750 million in an initial public offering on Wednesday, July 15th 2020. The company issued 39,500,000 shares at a price of $18.00-$20.00 per share. Goldman Sachs, BofA Securities and Morgan Stanley served as the underwriters for the IPO and Barclays, Credit Suisse, Evercore ISI, RBC Capital Markets, William Blair, Cantor, SunTrust Robinson Humphrey and Loop Capital Markets were co-managers.

How do I buy shares of GoHealth?

Shares of GOCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GOCO) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners